Iovance Biotherapeutics Inc (IOVA)
13.63
+0.75
(+5.82%)
USD |
NASDAQ |
May 03, 16:00
13.58
-0.05
(-0.37%)
After-Hours: 20:00
Iovance Biotherapeutics PE Ratio
PE Ratio Chart
Historical PE Ratio Data
| Date | Value |
|---|---|
| June 25, 2013 | 0.841 |
| June 21, 2013 | 0.8206 |
| June 19, 2013 | 1.045 |
| June 17, 2013 | 1.070 |
| June 11, 2013 | 1.024 |
| June 10, 2013 | 2.039 |
| June 07, 2013 | 2.039 |
| June 06, 2013 | 2.044 |
| June 05, 2013 | 2.727 |
| June 04, 2013 | 2.803 |
| June 03, 2013 | 2.803 |
| May 31, 2013 | 2.498 |
| May 30, 2013 | 1.911 |
| Date | Value |
|---|---|
| May 29, 2013 | 1.310 |
| May 28, 2013 | 0.7696 |
| May 20, 2013 | 0.7645 |
| May 13, 2013 | 0.7645 |
| May 07, 2013 | 0.5148 |
| May 03, 2013 | 3.058 |
| April 19, 2013 | 0.8665 |
| April 12, 2013 | 0.6116 |
| April 11, 2013 | 1.835 |
| April 10, 2013 | 1.850 |
| April 05, 2013 | 1.045 |
| April 04, 2013 | 2.039 |
| April 03, 2013 | 1.045 |
Price to Earnings Ratio (PE Ratio) Definition
The Price to Earnings Ratio (PE Ratio) is calculated by taking the stock price / EPS Diluted (TTM). This metric is considered a valuation metric that confirms whether the earnings of a company justifies the stock price. There isn't necesarily an optimum PE ratio, since different industries will have different ranges of PE Ratios. Because of this, PE Ratio is great to evaluate from a relative standpoint with other similar companies.
PE Ratio Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
PE Ratio Benchmarks
PE Ratio Related Metrics
| Price to Book Value | 6.512 |
| Price | 13.63 |
| Earnings Yield | -13.79% |
| Market Cap | 3.807B |